What is the recommended management for oral ulcers in a patient receiving everolimus?

Management of Everolimus-Induced Oral Ulcers

Prophylactic Dexamethasone Mouthwash is the Standard of Care

Begin prophylactic dexamethasone mouthwash (0.5 mg per 5 mL) on day 1 of everolimus therapy: swish 10 mL for 2 minutes and spit, four times daily for 8 weeks. 1

This approach reduces grade 2 or worse stomatitis incidence from 33% to just 2% compared to no prophylaxis, representing a dramatic 94% relative risk reduction. 1 The SWISH trial demonstrated this preventive strategy substantially decreases both incidence and severity of everolimus-related stomatitis and should be considered the new standard of oral care. 1, 2

---

First-Line Treatment Algorithm

For Grade 1 Stomatitis (Erythema Only)

• Continue everolimus at current dose 3
• Use 0.9% saline or sodium bicarbonate rinses to soothe the mouth 3
• Apply non-alcoholic mouthwashes only 3
• Consider prophylaxis against fungal, viral, and bacterial infections 3
• Treat any secondary infections with topical or systemic antimicrobials as needed 3

For Grade 2 Stomatitis (Patchy Ulcerations or Pseudomembranes)

• Consider dose interruption or reduction if intolerable for the patient 3
• Apply topical anesthetics such as viscous lidocaine 2% before meals 4, 5
• Use benzydamine hydrochloride rinse or spray every 3 hours, particularly before eating 4, 6, 5
• Apply mucoprotectant mouthwashes (e.g., Gelclair) three times daily to form a protective coating 4, 5
• Use betamethasone sodium phosphate 0.5 mg in 10 mL water as a rinse-and-spit preparation four times daily 4, 6, 5
• For localized ulcers, apply clobetasol gel or ointment (0.05%) directly to dried ulcer sites 4, 5

For Grade 3 Stomatitis (Severe Ulceration)

• Discontinue everolimus immediately 3
• Hospitalize for supportive care 3
• Administer appropriate pain relief and antimicrobials 3
• Restart everolimus at a lower dose once toxicity resolves to grade ≤1 3

---

Essential Supportive Care Measures

Oral Hygiene Protocol

• Clean the mouth daily with warm saline mouthwashes 4, 5
• Use antiseptic oral rinses twice daily (1.5% hydrogen peroxide or 0.2% chlorhexidine digluconate) 4, 5
• If chlorhexidine causes excessive stinging, dilute by 50% 6
• Apply white soft paraffin ointment to lips every 2 hours if affected 4, 5

Dietary Modifications

• Eat soft, moist, non-irritating food that is easy to chew and swallow 3
• Avoid acidic, spicy, salty, or rough/coarse foods 3
• Serve food at room temperature or cold 3
• Supplement meals with high-calorie/high-protein drinks 3
• Drink plenty of water 3
• Use lip balm for dry lips 3

Management of Secondary Infections

• If candidal infection is suspected, treat with nystatin oral suspension 100,000 units four times daily for 1 week 5
• Alternatively, use miconazole oral gel 5-10 mL held in mouth after food four times daily for 1 week 5
• Never use corticosteroid rinses if active infection is present—treat candidiasis first or concurrently 6

---

Second-Line Options for Refractory Cases

• Apply tacrolimus 0.1% ointment twice daily for 4 weeks 6, 5
• Consider intralesional triamcinolone injections weekly (total dose 28 mg) combined with topical clobetasol 4, 6, 5
• For highly symptomatic or recurrent ulcers, use systemic corticosteroids (prednisone/prednisolone 30-60 mg or 1 mg/kg for 1 week with tapering over the second week) 4, 6

---

Critical Pitfalls to Avoid

• Do not taper corticosteroids prematurely before disease control is established 4
• Evaluate dental appliances (braces, dentures, retainers) before therapy begins, as they can aggravate oral mucositis 3
• Refer to specialist for any oral ulcer lasting more than 2 weeks or not responding to 1-2 weeks of treatment 4
• Maintain good oral hygiene throughout treatment—this is essential for prevention 3

---

Evidence Strength and Nuances

The prophylactic dexamethasone approach is supported by the strongest evidence from the 2017 SWISH trial, which showed a dramatic reduction in stomatitis incidence. 1 However, a 2023 randomized trial (Alliance A221701) found no significant difference between prophylactic versus therapeutic dexamethasone, though this study was severely limited by poor enrollment (only 39 patients). 7 Given the overwhelming benefit demonstrated in the larger SWISH trial and the 2020 Oral Care-BC trial's conclusion that "dexamethasone mouthwash prophylaxis is standard treatment before everolimus," prophylactic use remains the evidence-based recommendation. 1, 2

Professional oral care (teeth cleaning, scaling, tongue cleaning) reduces grade 2 mucositis from 54% to 35%, but this 19% absolute reduction is less impressive than dexamethasone prophylaxis and should be considered adjunctive rather than primary prevention. 2

Everolimus-induced oral ulcers are dose-dependent: as daily dose increases, time to ulcer onset shortens and duration lengthens. 8 This complication affects 72% of patients and represents a key compliance issue with mTOR inhibitors. 8